SCHEMBL7094650

SCHEMBL7094650

CNC(=O)Nc1ccccc1O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.76
RECQL P46063 1/20 0.76
SMN1; SMN2 Q16637 1/20 0.76
NPC1 O15118 4/20 0.58
RAB9A P51151 4/20 0.58
GAA P10253 5/20 0.57
MAPT P10636 4/20 0.57
LMNA P02545 2/20 0.57
HTT P42858 2/20 0.57
TP53 P04637 2/20 0.55
KMT2A Q03164 4/20 0.55
MEN1 O00255 3/20 0.55
TDP1 Q9NUW8 2/20 0.55
KDM4E B2RXH2 1/20 0.55
POLB P06746 2/20 0.51
HPGD P15428 1/20 0.51
EPHX2 P34913 1/20 0.50
GRIK1 P39086 1/20 0.49
METAP2 P50579 1/20 0.47
MMP1 P03956 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14003501 0.87 ALDH1A1 (1.00) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL9400389 0.87 NPC1 (0.66) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL13804530 0.84 ALDH1A1 (0.64) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL29473466 0.83 NPC1 (0.55) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL28416832 0.81 ALDH1A1 (0.87) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL7254971 0.81 ALDH1A1 (0.72) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL9038777 0.79 NPC1 (0.58) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL8369698 0.79 ALDH1A1 (0.76) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL1951110 0.79 GAA (0.61) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A
SCHEMBL14850288 0.79 GAA (0.71) ALDH1A1RECQLSMN1; SMN2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6635091-B2 Oxidation color dye and coupler L'OREAL S. A. (FR) 2003-10-21 US claimed
US-20020178512-A1 Oxidation dyeing composition for keratinous fibres comprising a n-(2-hydrobenzene)-carbamate or a n-(2-hydroxy-benzene)-urea and a pyrazolopyrimine, dyeing methods L'OREAL SA (FR) 2002-12-05 US claimed
US-20010034914-A1 Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods L'OREAL S.A. (FR) 2001-11-01 US claimed
EP-1129689-A2 Keratinous fiber dyeing composition comprising N-(2-hydroxybenzene)-carbamate or N-(2-hydroxybenzene)urea derivatives as coupling agents and process for dyeing L'OREAL (FR) 2001-09-05 EP claimed
JP-58052280-A None JP disclosed
JP-59193810-A None JP disclosed
EP-3400210-B1 \"MULTI-TARGET\" COMPOUNDS WITH INHIBITORY ACTIVITY TOWARDS HISTONE DEACETYLASES AND TUBULIN POLYMERISATION, FOR USE IN THE TREATMENT OF CANCER UNIV PARIS SACLAY (FR) 2021-09-29 EP disclosed
US-9845297-B2 Antimicrobial compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2017-12-19 US disclosed
US-20160031828-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME SILICON VALLEY BANK 2016-02-04 US disclosed
US-9216979-B2 Antimicrobial compounds and methods of making and using the same MELINTA THERAPEUTICS, INC. (US) 2015-12-22 US disclosed
US-20130090326-A1 Antimicrobial Compounds and Methods of Making and Using the Same RIB-X PHARMACEUTICALS, INC. (US) 2013-04-11 US disclosed
US-7553796-B2 Phenol compound, reversible thermosensitive recording medium, reversible thermosensitive recording label, reversible thermosensitive recording member, image-processing apparatus and image-processing method RICOH COMPANY, LTD. (JP) 2009-06-30 US disclosed
US-20010034914-A1 Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods L'OREAL S.A. (FR) 2001-11-01 US disclosed
EP-1129689-A2 Keratinous fiber dyeing composition comprising N-(2-hydroxybenzene)-carbamate or N-(2-hydroxybenzene)urea derivatives as coupling agents and process for dyeing L'OREAL (FR) 2001-09-05 EP disclosed
WO-2001062220-A1 OXIDATION DYEING COMPOSITION FOR KERATINOUS FIBRES COMPRISING A N-(2-HYDROBENZENE)-CARBAMATE OR A N-(2-HYDROXY-BENZENE)-UREA AND A PYRAZOLOPYRIMINE, DYEING METHODS L'OREAL (FR) 2001-08-30 WO disclosed
US-5731127-A WEAR RESISTANCE, SOLVENT RESISTANCE DAINIPPON INK AND CHEMICALS, INC. (JP) 1998-03-24 US disclosed
EP-0737896-A2 Photosensitive composition and photosensitive planographic printing plate DAINIPPON INK AND CHEMICALS, INC. (JP) 1996-10-16 EP disclosed
JP-S59193810-A HERBICIDE MITSUBISHI PETROCHEM CO LTD 1984-11-02 JP disclosed
US-4404356-A USING A 2-HYDROXYPHENYL UREA AS CORING AGENT; STORAGE STABILITY; CASTINGS; MOLDING MATERIALS CIBA-GEIGY CORPORATION (US) 1983-09-13 US disclosed
JP-S5852280-A SUBSTITUTED PHENYLUREA DERIVATIVE, ITS PREPARATION, AND SELECTIVE HERBICIDE CONTAINING SAID COMPOUND NISSAN CHEM IND LTD 1983-03-28 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090326-A1 Antimicrobial Compounds and Methods of Making and Using the Same MPO, LPO, CAT ALDH1A1 1117/4885RECQL 1967/4885SMN1; SMN2 3979/4885
US-20010034914-A1 Compositions for the oxidation dyeing of keratinous fibers comprising at least one coupler, and dyeing methods KRT18, FH, FGB ALDH1A1 352/4885RECQL 2602/4885SMN1; SMN2 4369/4885
US-20020178512-A1 Oxidation dyeing composition for keratinous fibres comprising a n-(2-hydrobenzene)-carbamate or a n-(2-hydroxy-benzene)-urea and a pyrazolopyrimine, dyeing methods FH, KRT18, CYB5R3 ALDH1A1 389/4885RECQL 1441/4885SMN1; SMN2 4375/4885
US-20160031828-A1 ANTIMICROBIAL COMPOUNDS AND METHODS OF MAKING AND USING THE SAME MPO, LPO, CAT ALDH1A1 1117/4885RECQL 1967/4885SMN1; SMN2 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.